- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.
0 Comments | M2 Presswire, January, 2008
M2 PRESSWIRE-9 January 2008-BeaconEquityResearch.com: Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:09012008
To sign up for our free research reports and newsletters, visit http://beaconequityresearch.com/CHKT
January 08, 2008 - Chemokine Therapeutics Receives Approval From FDA to Commence Phase II Study
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Portfolio forecasting tools: what you need to know
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Humans, aliens & autism
- Fighting financial reporting fraud
- Personality and organizational citizenship behavior
- SAS #82: sword or shield?
- Taylor Fund L.P. Gains 40.53% in Third Quarter